New cancer clinical trial: Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors

Published on: June 27, 2018 at 12:00PM
Condition:   Kidney Cancer
Interventions:   Combination Product: CK2 and ATM inhibitors serine/ threonin Kinase combination;   Drug: Sunitinib;   Drug: Pazopanib;   Drug: Temsirolimus
Sponsor:   University Hospital, Grenoble
Recruiting
https://ift.tt/2Ms7VCW